Fei Lai

Fei Lai

Auto-generated profile, based on publicly available information

Fei Lai

Department of Dermatology, Tallaght University Hospital , Dublin

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2024 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
CQClaire Quigley
Claire Quigley
CHClaudine Howard-James
Claudine Howard-James
HYHelena Yhoo
Helena Yhoo
FLFei Lai
Fei Lai
JYJiFung Yong
JiFung Yong
GMGregg Murray
Gregg Murray
We conducted informal and formal trend analysis on the term ‘sunbed’ assessing its search popularity, identifying the top-three social media (SM) sites where the term is mentioned, characterizing the persons or groups most likely to post about sunbeds and analysing the content that is most frequently being made available in relation to sunbeds. We found a statistically significant increase in the search trend for the term ‘sunbed’ between 2008 and 2023. While Instagram had the most sunbed mentions, TikTok videos had more viewer engagement. TikTok had more influencer-driven sunbed posts than the other SM platforms. Commercial premises posting about sunbed use featured heavily on Instagram (56%) and TikTok (40%). Our study highlights the harmful influence SM can have.

28 May 2025 in JEADV Clinical Practice
Verified
Journal Article
Open access
JYJi Fung Yong
Ji Fung Yong
FLFei Lai
Fei Lai
CQClaire Quigley
Claire Quigley
LYLi Jie Helena Yoo
Li Jie Helena Yoo
CHClaudine Howard‐James
Claudine Howard‐James
ATAnne‐Marie Tobin
Anne‐Marie Tobin
Background: Methotrexate, originally an anti‐neoplastic agent, is now extensively used at lower doses in dermatology and rheumatology for chronic inflammatory conditions. While its safety is supported by routine blood monitoring, there remains variability in recommended monitoring frequency, folic acid supplementation, liver function testing and the role of specific biomarkers like Type III Procollagen Peptide (PIIINP).Objectives: This study aimed to compare methotrexate prescribing and monitoring practices in Ireland with various national guidelines, including those from the European Medicines Agency (EMA), British Association of Dermatologists (BAD) and European Alliance of Associations for Rheumatology (EULAR). The goal was to document current practices among dermatologists and rheumatologists in Ireland to identify any discrepancies in methotrexate prescribing and monitoring.Methods: An online survey was distributed to members of the Irish Association of Dermatologists (IAD) and the Irish Society of Rheumatology (ISR) in July 2024. The questionnaire covered pretreatment screening, blood monitoring practices, folic acid supplementation and adverse events. Data was finalised and analysed in September 2024.Results: Of the 52 respondents, all conducted baseline full blood count (FBC), renal profile (RP) and liver function tests (LFTs). Dermatologists were significantly more likely to perform infectious disease screenings compared to rheumatologists (p < 0.05). When initiating methotrexate, only 17 practitioners (32.7%) employed a test dose of 2.5–5 mg weekly, with a statistically significant difference (p < 0.05) observed in the starting doses of methotrexate. All respondents prescribed folic acid supplementation, with a statistically significant (p < 0.05) noted in supplementation practices between the two specialties. Abnormal LFTs/PIIINP prompted hepatology referrals for 48%. Seven (13%) reported irreversible liver damage cases, and one (2%) death from pneumonia was noted.Conclusions: This study highlights significant discrepancies in methotrexate prescribing and monitoring practices among Irish clinicians, similar to the various international guidelines. These variations underscore the need for updated, unified guidelines to ensure consistent and safe methotrexate use across the specialties.

22 November 2025 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
CHClaudine Howard-James
Claudine Howard-James
GMGregg Murray
Gregg Murray
FHFatma Al Hosni
Fatma Al Hosni
MMMichael Maguire
Michael Maguire
FLFei Lai
Fei Lai
ATAnne-Marie Tobin
Anne-Marie Tobin
Hidradenitis suppurativa (HS) is a chronic inflammatory condition associated with multimorbidity. Frailty is a syndrome of decreased reserve, the prevalence of which increases with multimorbidity and is associated with increased mortality as well as health resource utilization and costs. This case–control study is the first to quantify frailty in HS, and we report statistically worse frailty scores and higher body mass index in patients with HS compared with non-HS controls.

6 May 2025 in Skin Health and Disease
Verified
Journal Article
Open access
FLFei Ya Lai
Fei Ya Lai
CQClaire Quigley
Claire Quigley
GMGregg Murray
Gregg Murray
AGAmanda Gordon
Amanda Gordon
JYJi Fung Yong
Ji Fung Yong
ATAnne-Marie Tobin
Anne-Marie Tobin
Background: Indoor tanning through sunbeds is linked to a heightened risk of skin cancers, particularly cutaneous squamous cell carcinoma and basal cell carcinoma, with significant increases in risk for users aged < 35 years. Despite regulations established by the Public Health (Sunbeds) Act 2014 in Ireland, sunbed use persists, primarily for cosmetic reasons. Objectives: To analyse the characteristics, attitudes and behaviours of sunbed users attending an Irish dermatology outpatient clinic. Methods: We undertook a prospective qualitative analysis of 104 consecutive patients attending a pigmented lesion clinic in a tertiary referral dermatology department in Ireland. This was done using a self-reported anonymous survey where respondents answered questions relating to their own demographic data, frequency of sunbed use, motivation for sunbed use and use of unregulated tan-enhancing agents (namely Melanotan I and II). Results: The results showed that patient demographics were consistent with previous studies on sunbeds use, namely younger female patients living in urban areas. Many sunbed premises did not comply with safety regulations; over half lacked protective goggles, and nearly half received no health risk information. The reasons for sunbed use included improving appearance and confidence, with a significant number using tan-enhancing agents. Surprisingly, increased awareness of health risks did not correlate with reduced usage; many users continued tanning practices despite concerns about its adverse effects. Users of tan-enhancing agents also used sunbeds more frequently compared with nonusers. Conclusions: This study suggests a potential psychopathological aspect of tanning behaviours similar to addictive disorders like smoking and alcohol. Patients may benefit from psychological and behavioural interventions such as cognitive behavioural therapy to address their compulsive behaviour. Furthermore, there was a concerning lack of compliance with regulations in tanning salons, highlighting a public health issue. The rising use of unregulated tanning agents, especially among younger people, poses additional risks, including blood-borne infections. This study underscores the need for targeted educational interventions among younger age groups and stricter enforcement of regulations to mitigate health risks associated with indoor tanning. Understanding the complex motivations behind sunbed use is crucial for developing effective strategies to reduce its prevalence and promote safer alternatives.

12 October 2025 in JEADV Clinical Practice
Verified
Journal Article
Open access
CHClaudine Howard‐James
Claudine Howard‐James
FLFei Ya Lai
Fei Ya Lai
SCStephen Crowther
Stephen Crowther
MCMaureen Connolly
Maureen Connolly

30 January 2025 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
JYJi Fung Yong
Ji Fung Yong
FLFei Lai
Fei Lai
CHCaitriona Hackett
Caitriona Hackett
ATAnne-Marie Tobin
Anne-Marie Tobin
Itch, or pruritus, is a common and unpleasant sensation transmitted by both the peripheral and central nervous systems, sharing pathways with pain sensation. The itch pathway is complex, and itch is a perplexing symptom. We report a patient whose presentation following a spinal stroke highlights the potential mechanism of neuropathic itch, the challenges in managing chronic neuropathic itch and dysaesthesia and the importance of a holistic approach in treating patients who have these symptoms.